B. Braun Medical Inc., a leader in infusion therapy and pain management, has started purchasing renewable electricity for its operations in the U.S., leading to a significant reduction of Greenhouse Gas (GHG) emissions and furthering its dedication to protecting people and the planet by reducing environmental impact. This action will result in a greater than 30% reduction of B. Braun’s scopes 1 & 2 CO2e emissions in North America and represents a significant investment in renewable energy deployment.
The purchase agreements are part of B. Braun’s commitment to reducing CO2e emissions 50% by 2030 and will result in all of the company’s U.S. based manufacturing facilities, affiliated distribution centers and locations in Pennsylvania being matched with 100% renewably sourced electricity from 2026 onwards. B. Braun is also taking additional steps to invest in alternative energy technologies, including the installation of a fuel cell microgrid at B. Braun’s 710,000 sq. ft. IV fluid and generic pharmaceutical manufacturing facility in Irvine, California.
